Showing results (211-220 of 235) with videos related to
Sort By:
Pageof 24
The Journal of Experimental Medicine|April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infectionRika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.AIDS Research and Human Retroviruses|June 10, 2004
Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and caucasiansXu G Yu, Marylyn M Addo, Beth A Perkins, et al.Journal of Virology|April 25, 2008
HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral loadChristine M Rousseau, Marcus G Daniels, Jonathan M Carlson, et al.Journal of Virology|November 24, 2006
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypesXu G Yu, Mathias Lichterfeld, Senica Chetty, et al.Nature Communications|February 21, 2024
Converging and evolving immuno-genomic routes toward immune escape in breast cancerJuan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado, et al.Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.Nature Medicine|December 19, 2006
CD8+ T-cell responses to different HIV proteins have discordant associations with viral loadPhotini Kiepiela, Kholiswa Ngumbela, Christina Thobakgale, et al.Ebiomedicine|April 15, 2016
Gut Microbiota Linked to Sexual Preference and HIV InfectionMarc Noguera-Julian, Muntsa Rocafort, Yolanda Guillén, et al.Ebiomedicine|March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcomeBruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.Frontiers in Immunology|May 22, 2020
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, et al.Pageof 24